Abstract
Alkaptonuria (AKU) is a rare inherited disease resulting from a deficiency of the enzyme homogentisate 1,2‐dioxygenase which leads to the accumulation of homogentisic acid (HGA). AKU is characterized by severe cartilage degeneration, similar to that observed in osteoarthritis. Previous studies suggest that AKU is associated with alterations in cytoskeletal organization which could modulate primary cilia structure/function. This study investigated whether AKU is associated with changes in chondrocyte primary cilia and associated Hedgehog signaling which mediates cartilage degradation in osteoarthritis. Human articular chondrocytes were obtained from healthy and AKU donors. Additionally, healthy chondrocytes were treated with HGA to replicate AKU pathology (+HGA). Diseased cells exhibited shorter cilia with length reductions of 36% and 16% in AKU and +HGA chondrocytes respectively, when compared to healthy controls. Both AKU and +HGA chondrocytes demonstrated disruption of the usual cilia length regulation by actin contractility. Furthermore, the proportion of cilia with axoneme breaks and bulbous tips was increased in AKU chondrocytes consistent with defective regulation of ciliary trafficking. Distribution of the Hedgehog‐related protein Arl13b along the ciliary axoneme was altered such that its localization was increased at the distal tip in AKU and +HGA chondrocytes. These changes in cilia structure/trafficking in AKU and +HGA chondrocytes were associated with a complete inability to activate Hedgehog signaling in response to exogenous ligand. Thus, we suggest that altered responsiveness to Hedgehog, as a consequence of cilia dysfunction, may be a contributing factor in the development of arthropathy highlighting the cilium as a novel target in AKU.
Highlights
Alkaptonuria (AKU) is an ultra-rare metabolic disease in which a deficiency of the enzyme homogentisate 1,2-dioxygenase leads to the accumulation of homogentisic acid (HGA) (La Du, Zannoni, Laster, & Seegmiller, 1958); for review see Gallagher, Dillon, Sireau, Timmis, and Ranganath (2016)
Gene expression was evaluated in untreated chondrocytes from the three groups (Healthy, AKU, and +HGA) and chondrocytes from each group treated for 24 hr with 1 μg/ml recombinant Indian Hedgehog (Ihh; R&D Systems, Abingdon, UK) to measure pathway activity
These studies are the first to show that primary cilia structure and function are disrupted in the ultra-rare metabolic disorder AKU, and that aspects of this cilia phenotype can be replicated by treatment with HGA
Summary
Alkaptonuria (AKU) is an ultra-rare metabolic disease in which a deficiency of the enzyme homogentisate 1,2-dioxygenase leads to the accumulation of homogentisic acid (HGA) (La Du, Zannoni, Laster, & Seegmiller, 1958); for review see Gallagher, Dillon, Sireau, Timmis, and Ranganath (2016). The bone surfaces where it has a protective, low friction, load distributing function (Mow, Wang, & Hung, 1999) This cartilage tissue matrix is largely comprised of a dense collagen network in which the highly hydrated glycosaminoglycan, aggrecan, is immobilized. Chondrocytes reside within this matrix and are responsible for maintaining tissue homeostasis in response to mechanical cues. Disruption of this process results in the degenerative disease osteoarthritis (OA), which is characterized by progressive failure of the articular cartilage accompanied by changes in the synovium and subchondral bone that result in loss of mobility and significant pain (Goldring & Goldring, 2007). Despite being the world’s most common form of arthropathy, there is currently no treatment to prevent OA
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have